ReviewFrontiers in oncology2025

PARP inhibitors as radiosensitizers: a comprehensive review of preclinical evidence and clinical applications.

Xiaodong Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.